10.1371/journal.pone.0102180.g006 Takashi Temma Takashi Temma Hirofumi Hanaoka Hirofumi Hanaoka Aki Yonezawa Aki Yonezawa Naoya Kondo Naoya Kondo Kohei Sano Kohei Sano Takeharu Sakamoto Takeharu Sakamoto Motoharu Seiki Motoharu Seiki Masahiro Ono Masahiro Ono Hideo Saji Hideo Saji MDAP<sub>CV</sub> (%) present in tumors after intratumoral injection of MDAP<sub>3000</sub> with or without MMP inhibitor (GM6001). Public Library of Science 2014 Biochemistry enzymology Enzyme chemistry Enzyme regulation enzymes biophysics Bionanotechnology biotechnology biomaterials Small molecules neuroscience neuroimaging Single photon emission computed tomography Clinical medicine oncology Basic cancer research metastasis Cancer treatment Radiation therapy Cancer detection and diagnosis Oncology agents pharmacology Drug research and development drug discovery pharmacokinetics Drug distribution Radiopharmaceuticals Radiology and imaging chemistry Nuclear chemistry Radiochemistry tumors intratumoral injection mmp inhibitor 2014-07-10 03:14:32 Figure https://plos.figshare.com/articles/figure/_MDAP_CV_present_in_tumors_after_intratumoral_injection_of_MDAP_3000_with_or_without_MMP_inhibitor_GM6001_/1099560 <p>MDAP<sub>CV</sub> (%) present in tumors after intratumoral injection of MDAP<sub>3000</sub> with or without MMP inhibitor (GM6001).</p>